1. Detection of circulating BMP5 as a risk factor for Barrett's esophagus.
- Author
-
Correia ACP, Calpe S, Mostafavi N, Hoefnagel SJM, Sancho-Serra MDC, de Koning PS, and Krishnadath KK
- Subjects
- Aged, Barrett Esophagus genetics, Barrett Esophagus pathology, Bone Morphogenetic Protein 2 blood, Bone Morphogenetic Protein 2 genetics, Bone Morphogenetic Protein 4 blood, Bone Morphogenetic Protein 4 genetics, Bone Morphogenetic Protein 5 genetics, Female, Gene Expression Regulation genetics, Humans, Male, Middle Aged, Risk Factors, Barrett Esophagus blood, Biomarkers blood, Bone Morphogenetic Protein 5 blood
- Abstract
Barrett's esophagus (BE) predisposes for the malignant condition of esophageal adenocarcinoma (EAC). Since BE patients have few or no symptoms, most of these patients are not identified and not included in surveillance programs. These BE patients are at risk of developing advanced-stage EAC. At present, non-invasive tests to identify BE patients from the general population are lacking. We and others showed that Bone Morphogenetic Protein 4 (BMP4), and other BMPs are upregulated in BE. We aimed to determine if circulating BMPs can be identified and used as blood biomarkers to identify BE patients at high risk in the general population. In this study, we could detect the different BMPs in the blood of 112 BE patients and 134 age- and sex-matched controls. Concentration levels of BMP2, BMP4, and BMP5 were elevated in BE patients, with BMP2 and BMP5 significantly increased. BMP5 remained significant after multivariate analysis and was associated with an increased risk for BE with an OR of 1.49 (p value 0.01). Per log (pg/mL) of BMP5, the odds of having BE increased by 50%. Future optimization and validation studies might be needed to prove its utility as a non-invasive method for the detection of BE in high-risk populations and screening programs.
- Published
- 2020
- Full Text
- View/download PDF